Hemostemix Announces Director Resignation
November 22, 2019 16:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Nov. 22, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and...
Hemostemix Provides Corporate Update
November 19, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
Hemostemix Provides Corporate Update
October 31, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), is a biotechnology company developing and commercializing...
Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract
October 21, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
Hemostemix Announces Commencement of Arbitration
October 17, 2019 07:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and...
Hemostemix Announces $2 Million Loan Facility
August 01, 2019 08:30 ET
|
Hemostemix Inc.
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Aug. 01, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
Hemostemix Announces Financing Update and Interim CFO Appointment
July 11, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, July 11, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and...
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
July 02, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, July 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
June 27, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40)...
Hemostemix Announces Resignation of CFO
June 25, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, June 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and...